Price
761.55
-0.54%52W Range
Market Cap
₹39,457.51 Cr
Traded: ₹265.40 Cr (0.67%) 0.0x
Free Float: ₹5,764.74 Cr (4.60% of FF traded)
Volume · 60D trend
34.94 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | +8.0% | +9.0% | +7.0% | -- | -- | Stable |
| Return | -- | +37.0% | +45.0% | +46.0% | -- | Accelerating |
| Sales | -1.0% | -12.0% | +16.0% | -- | +12.0% | Stable |
| Profit | +48.0% | +23.0% | -1.0% | -- | +37.0% | Stable |
Quarterly Results
Mar 2023
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,311 | 1,182 | 1,186 | 1,197 | 1,078 | 1,000 | 1,050 | 1,086 | 1,002 | 974 | 955 | 929 | 841 | 807 | 3,192 |
| Expenses | 1,055 | 958 | 983 | 961 | 876 | 818 | 864 | 869 | 841 | 817 | 805 | 787 | 722 | 687 | 2,743 |
| Operating Profit | 256 | 224 | 202 | 236 | 202 | 182 | 186 | 217 | 161 | 156 | 149 | 142 | 119 | 120 | 449 |
| OPM % | 20.0% | 19.0% | 17.0% | 20.0% | 19.0% | 18.0% | 18.0% | 20.0% | 16.0% | 16.0% | 16.0% | 15.0% | 14.0% | 15.0% | 14.0% |
| Other Income | -77 | 37 | 0 | 28 | 29 | 5 | 9 | 35 | 5,120 | -40 | 153 | -64 | -17 | 149 | 10 |
| Interest | 31 | 30 | 31 | 31 | 31 | 32 | 31 | 31 | 29 | 30 | 25 | 30 | 25 | 25 | 87 |
| Depreciation | 69 | 67 | 68 | 66 | 63 | 64 | 62 | 62 | 60 | 58 | 57 | 54 | 51 | 54 | 198 |
| Profit Before Tax | 78 | 163 | 103 | 167 | 136 | 91 | 102 | 159 | 5,191 | 28 | 220 | -7 | 26 | 190 | 173 |
| Tax % | 62.0% | 6.0% | 43.0% | 27.0% | 31.0% | 6.0% | 37.0% | 33.0% | 1.0% | 108.0% | 5.0% | 120.0% | 24.0% | 4.0% | 8.0% |
| Net Profit | 29 | 154 | 59 | 121 | 94 | 86 | 64 | 106 | 5,152 | -2 | 209 | -15 | 20 | 183 | 159 |
| Exceptional Items | -- | 0 | -28 | -0 | -4 | -26 | -24 | 0 | 5,071 | -44 | 144 | -68 | -25 | 133 | 0 |
| EPS (Rs) | 0.3 | 2.7 | 1.0 | 2.1 | 1.6 | 1.6 | 1.1 | 1.9 | 103.0 | -0.5 | 3.6 | -0.6 | 0.1 | 3.4 | 2.8 |
| Sales Growth (YoY) | -- | 18.2% | 12.9% | 10.2% | 7.6% | 2.8% | 10.0% | 16.9% | 19.1% | 20.6% | -70.1% | -67.0% | -68.4% | -70.4% | -- |
| Sales Growth (QoQ) | -- | -0.3% | -0.9% | 11.0% | 7.8% | -4.8% | -3.3% | 8.4% | 2.9% | 2.0% | 2.8% | 10.5% | 4.2% | -74.7% | -- |
| OP Growth (YoY) | 26.7% | 23.1% | 8.6% | 8.8% | 25.5% | 16.7% | 24.8% | 52.8% | 35.3% | 30.0% | -66.8% | -- | -- | -- | -- |
| OP Growth (QoQ) | 14.3% | 10.9% | -14.4% | 16.8% | 11.0% | -2.2% | -14.3% | 34.8% | 3.2% | 4.7% | 4.9% | 19.3% | -0.8% | -73.3% | -- |
| Profit Growth (YoY) | -- | 42.0% | -10.0% | 14.0% | 9.0% | 396.0% | 25.0% | 159.0% | 633.0% | -57.0% | -60.0% | -19.0% | -84.0% | -80.0% | -6.0% |
| EPS Growth (YoY) | -- | 71.5% | -11.4% | 9.3% | -98.4% | 429.2% | -68.3% | 412.9% | 102900.0% | -114.0% | 28.7% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 168.3% | -52.4% | 28.5% | 4.4% | 38.6% | -41.2% | -98.1% | 21558.3% | -113.4% | 679.0% | -720.0% | -97.1% | 22.6% | -- |
| OP Margin | -- | 18.9% | 17.0% | 19.7% | 18.7% | 18.2% | 17.7% | 20.0% | 16.1% | 16.0% | 15.6% | 15.3% | 14.2% | 14.9% | 14.1% |
| Net Margin | -- | 13.0% | 5.0% | 10.1% | 8.7% | 8.6% | 6.1% | 9.8% | 514.2% | -0.2% | 21.9% | -1.6% | 2.4% | 22.7% | 5.0% |
| Material Cost % | -- | 22.3% | 22.6% | 22.6% | 22.9% | 22.5% | 23.5% | 21.9% | 22.8% | 23.8% | 24.0% | 25.4% | 26.0% | 25.5% | 29.9% |
| Employee Cost % | -- | 18.6% | 18.7% | 17.7% | 18.1% | 18.3% | 18.4% | 17.8% | 19.0% | 17.6% | 18.6% | 18.5% | 18.5% | 17.5% | 32.7% |
| P/S | 8.09 | 9.40 | 8.14 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 123.83 | 112.43 | 110.23 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 8.62 | 9.53 | 8.01 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August ....
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 21, 2026 for BCP Asia II Topco IV Pte Ltd
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for GLAS Trust (Singapore) Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Centella Mauritius Holdings Ltd
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Centella Mauritius Holdings Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Intimation regarding receipt of trading approval for equity shares allotted in terms of Scheme of Amalgamation
Transcript of earning conference call held for the quarter ended 30 June 2026
Newspaper publication regarding unaudited financial results for the quarter ended 30 June 2026
Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30 June 2026
Outcome of the Board Meeting - Unaudited Financial Results (standalone and consolidated) for the first quarter ended 30 June 2026
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Azad Moopen Mandayapurath & PACs
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BCP Asia II Topco IV Pte Ltd & PACs
Allotment of equity shares to the shareholders of Transferor Company (QCIL) pursuant to the Scheme of Amalgamation
Intimation of revised Credit Rating
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30 June 2026
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BCP Asia II Topco IV Pte Ltd
Intimation regarding Change of name of Company from Aster DM Healthcare Limited to Aster DM Quality Care Limited
Successful completion of the merger between Aster DM Healthcare and Quality Care India Limited
Updated outcome of the Meeting of the Board of Directors held on Wednesday, 1 July 2026 with additional details in response to e-mail received from BSE on 02 July 2026
Update on Scheme of Amalgamation of the Company with regard to Effective Date of the Scheme, change in promoter category, and amended MOA & AOA
Pursuant to Scheme of Amalgamation becoming effective, the MOA and AOA of the Company Stands amended w.e.f. 1 July 2026
Changes in the Board of Directors pursuant to Scheme of Amalgamation and consequent changes in the organisation structure with effect from 1 July 2026
Outcome of Board Meeting held on 1 July 2026: Changes in Directors, KMPs, SMPs and approval ESOP Scheme Plan
Resignation of Independent Directors and Non-Executive Directors
Changes in the Senior Management Personnel of the Company w.e.f. 1 July 2026
Contact details of Key Managerial Personnel of the Company authorised to determine materiality of an event or information and for making disclosure to stock exchanges
The Company acquired Optionally Convertible Redeemable Preference Shares in an Associate Company
Outcome of Board Meeting
Board of Directors at its meeting held on 25 June 2026 fixed 9 July 2026 as the record date for the purpose of determining the entitlement of the equity shareholders of Transferor Company ....
Intimation of trading window closure from 1st July 2026 till 48 hours of declaration of the unaudited financial results
The Company has received the Certified true copy of the order passed by the Hon''ble NCLT, Hyderabad Bench, approving the scheme of Amalgamation
Update on the allotment of Compulsorily convertible Preference Shares by a subsidiary company
We wish to inform you regarding the order passed by the Hon''ble NCLT, Hyderabad Bench, approving the Scheme of Amalgamation
The Company has acquired 4,50,89,995 equity shares of Rs. 10/- each through rights issue in Aster DM Super-Specialty (Sarjapur) Private Limited
Update on the allotment of Compulsorily Convertible Preference Shares by a subsidiary company
Newspaper Publication regarding notice to members pursuant to Section 201 of the Companies Act, 2013
Intimation of schedule of Analyst / Institutional Investors Meeting
Intimation of schedule of Analyst / Institutional Investors Meeting
Intimation of schedule of Analyst / Institutional Investors Meeting
Transcript of earning conference call held for quarter and year ended March 31, 2026
Newspaper publications regarding audited financial results for the quarter and year ended March 31, 2026
Video/Audio Recording of Earnings Call for the quarter and year ended March 31, 2026
Outcome of the Board Meeting held on April 30, 2026
Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026
Press release in relation to the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026
Investor presentation for the earning conference calls scheduled for May 1, 2026, in related to audited financial results for the quarter and year ended March 31, 2026
Intimation of schedule of Analyst/Investors call for Q4 and year ended March 31, 2026
Annual Reports
8Credit Ratings
6Concalls
51Feb 2026
28 Feb 2026Jan 2026
31 Jan 2026Nov 2025
30 Nov 2025Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Dec 2024
31 Dec 2024Nov 2024
30 Nov 2024Nov 2024
30 Nov 2024Oct 2024
31 Oct 2024Aug 2024
31 Aug 2024Jun 2024
30 Jun 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Feb 2024
29 Feb 2024Dec 2023
31 Dec 2023Nov 2023
30 Nov 2023Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023Jun 2023
30 Jun 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022Aug 2022
31 Aug 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Nov 2021
30 Nov 2021Sep 2021
30 Sept 2021Aug 2021
31 Aug 2021Jun 2021
30 Jun 2021Mar 2021
31 Mar 2021Feb 2021
28 Feb 2021Dec 2020
31 Dec 2020Nov 2020
30 Nov 2020Aug 2020
31 Aug 2020Jun 2020
30 Jun 2020Jun 2020
30 Jun 2020Feb 2020
29 Feb 2020Feb 2020
29 Feb 2020Nov 2019
30 Nov 2019Sep 2019
30 Sept 2019Aug 2019
31 Aug 2019Jun 2019
30 Jun 2019May 2019
31 May 2019Mar 2019
31 Mar 2019Feb 2019
28 Feb 2019Nov 2018
30 Nov 2018Sep 2018
30 Sept 2018Aug 2018
31 Aug 2018Jun 2018
30 Jun 2018Held by ETFs
19 ETFs hold ASTERDM · sorted by weight
Held by Mutual Funds
99 schemes hold ASTERDM · sorted by weight